Vimarsana
Biggest News Aggregation in the World

Page 4 - Aim Leukemia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aim Leukemia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aim Leukemia Today - Breaking & Trending Today

Curis Provides Fourth Quarter 2022 Business Update - Vimarsana News

Curis Provides Fourth Quarter 2022 Business Update

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Curis Provides Third Quarter 2022 Business Update - Vimarsana News

Curis Provides Third Quarter 2022 Business Update

Curis, Inc. , a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its business update and financial results for the third quarter... | November 10, 2022

Curis Announces Three Presentations at SITC 2022 - Vimarsana News

Curis Announces Three Presentations at SITC 2022

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

FDA Lifts Partial Clinical Hold on the TakeAim Lymphoma Study of Emavusertib - Vimarsana News

FDA Lifts Partial Clinical Hold on the TakeAim Lymphoma Study of Emavusertib

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Curis Reports Second Quarter 2022 Financial Results and Business Update - Vimarsana News

Curis Reports Second Quarter 2022 Financial Results and Business Update

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...